. . . . . . . "[Osteopontin overexpression is common in primary non-small cell lung cancer (NSCLC) and may be important in the cancer development and progression and osteopontin plasma levels may serve as a biomarker for diagnosing or monitoring patients with NSCLC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:16:25+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .